-
Innovation Ranking
NewInnovation Ranking – Hellenic Telecommunications Organization SA
Hellenic Telecommunications Organization SA (OTE) provides fixed and mobile telephony services. The company offers voice, broadband, internet access on 3G and 4G networks; television services; broadband and internet access services; satellite communication; and other related services. It also develops commercial spaces and telecom equipment. The company provides real estate and professional training services. The company also renders financing, e-commerce, retail, wholesale broadband and infrastructure services, electronic money services, ICT and marketing services through its subsidiaries. The company caters its services...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vilobelimab in Multiple Organ Failure (Multiple Organ Dysfunction Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vilobelimab in Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drug Details: Vilobelimab (Gohibic) is an...
-
Company Insights
Innovation and Patenting activity of Vinati Organics Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Vinati Organics Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
NewGeneric Drugs – Physician Perspective – Thematic Intelligence
Reasons to buy the ‘Generic Drugs – Physician Perspective’ thematic intelligence report: Assess healthcare professionals’ attitudes towards generic drugs prescription. Better understand the barriers to the production and uptake of generic medicines. Capture physicians’ opinions on generics substitution. Better understand patients’ preferences. Assess past and future generics uptake. Gain a better understanding of cost consideration when prescribing drugs. Explore the differences across markets. How is our ‘Generic Drugs – Physician Perspective’ report unique from other reports in the market? This...
-
Product Insights
NewLikelihood of Approval Analysis for Shock
Overview How likely is it that the drugs in Shock will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shock Overview Shock is a medical condition characterized by a significant and life-threatening...
-
Product Insights
NewLikelihood of Approval Analysis for Transplant Rejection
Overview How likely is it that the drugs in Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Transplant Rejection Overview Transplant rejection is the immune system's response to a...
-
Product Insights
NewLikelihood of Approval Analysis for Lung Transplant Rejection
Overview How likely is it that the drugs in Lung Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lung Transplant Rejection Overview Lung transplantation is the therapy used in...
-
Company Insights
Innovation and Patenting activity of Hellenic Telecommunications Organization SA Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Hellenic Telecommunications Organization SA Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Fine Organics Industries Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Fine Organics Industries Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...